Effects of nicotinic acid on phosphorus-calcium metabolism in patients with diabetic nephropathy
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 1
Abstract
Objective — to study the effects of therapy with the use of nicotinic acid on the clinical and laboratory parameters and the levels of FGF23, calcium and phosphorus in the serum of patients with diabetic nephropathy (DN). Materials and methods. In the dynamics of treatment, the examinations have been performed on 54 patients with type 2 diabetes mellitus, aged 46 to 78 years, with clinically significant nephropathy — proteinuria and decrease of the glomerular filtration rate. All patients received standard basic hypoglycemic and nephroprotective therapy. Patients with impaired calciumphosphorus metabolism were divided into the following groups: patients who received basic therapy and patients who were prescribed nicotinic acid in addition to basic therapy. The FGF23 levels in serum were determined by ELISA. Calcium and phosphorus serum concentrations were studied using a reagent kit from Cormay (Poland). Results and discussion. In patients with DN, impaired phosphoruscalcium metabolism is characterized by an increase in serum FGF23 and hyperphosphatemia. Combined therapy using nicotinic acid, as well as basic therapy, contributed to a significant decrease in the serum FGF23 content in patients. The additional administration of nicotinic acid, in contrast to the basic therapy, led to a significant decrease in phosphorus levels by 30 % (p < 0.05). Patients with DN which use basic therapy, a significant decrease in total cholesterol by 25.1 %, triglycerides by 42.7 % was found, in the group of patients, nicotinic acid was additionally obtained, a more significant decrease in these indicators was found, the level of total cholesterol decreased by 32.3 %, triglycerides by 51.4 %. Conclusions. Our findings suggest that direct effect of nephroprotective therapy on the content of circulating FGF23 and phosphorus levels in the blood serum and on the feasibility of using nicotinic acid to improve the cardionephroprotective strategy in the treatment of patients with DN.
Authors and Affiliations
I. I. Topchii, Yu. S. Yakimenko, V. Yu. Galchinska, P. S. Semenovykh, A. V. Tumka
Keywords
Related Articles
- EP ID EP583433
- DOI 10.30978/UTJ2019-1-18
- Views 121
- Downloads 0
Investigation of a new indicator of autoimmune accumulation in the genesis of type I diabetes mellitus
Objective — the search for the new marker of autoimmune accumulation in the genesis of type I diabetes mellitus (DM-1). Materials and methods. With the use of immune enzymatic assay, investigations have been performed of...
The model of adverse course of heart failure with account of the thyroid status of patients
Objective — to determine the predictors of adverse course of heart failure (HF) with account of the thyroid status of patients. Materials and methods. The study involved 157 patients with HF (and previous myocardial infa...
Effects of actovegin on the treatment efficacy of patients with gastroesophageal reflux disease with concomitant bronchial asthma
Objective — to study the actovegin effects on the clinical course of comorbid pathology, the quality of life of patients and the state of oxidative stress, that is, the level of aggression and protection factors, against...
Obesity in the development of coronary artery disease (according to population studies)
Studies of large groups of people within the framework of the big data approach show the key features of the multifactorial mechanisms for the development of comorbid pathology. Limit values, the sequence of shifts of th...
Metabolic disorders in patients with arterial hypertension with concomitant obesity
Objective — further investigation of the pathogenetic triggers of arterial hypertension with concomitant obesity. Materials and methods. Examinations involved 111 patients with arterial hypertension (AH) with concomitant...